The Effect of Rebox Current in Pain Management

Inclusion Criteria:

• Patient with pain based on the following diagnoses:

• Myofascial musculoskeletal pain

• Vertebrogenic algic syndrome in the cervical, thoracic and lumbosacral regions

• Sacroileitis with sacroiliac joint block

• Cervicocranialgia

• Frozen shoulder syndrome

• Arthrosis

• Epicondylitis

• Pain in tendons, ligaments and other enthesopathies

• Postoperative pain

• Post-traumatic pain

• Postherpetic neuralgia

• Duration of pain (de novo or exacerbation of chronic pain) prior to study inclusionranges from 2 weeks to 3 months

• The average pain intensity in a given period of 2 weeks to 3 months prior to studyinclusion must be NRS (Numerical Rating Scale) >3

• The patient may be concurrently treated with analgesics and may be undergoing manualphysiotherapy (rehabilitation)

Exclusion Criteria:

• Age <18 years

• Local contraindications:

• Impaired skin integrity at the site of application (open wound, skin ulcer,burns), Note: the area around the postoperative scar is not an exclusioncriterion

• Acute inflammation of the skin or subcutaneous tissue at the application site

• Deep vein thrombosis (diagnosed or suspected)

• General contraindications:

• Implanted electrical device (pacemaker, implantable cardioverter-defibrillator,deep brain stimulator, cochlear implant, etc.)

• Pregnancy

• Epilepsy

• Malignant cancer (diagnosed or suspected)

• Acute potentially life-threatening conditions

• Concomitant other physical therapy (electrotherapy, magnetotherapy, laser therapy,ultrasound therapy, mechanotherapy, etc.)

• The Rebox device was administered to the subject for any indication in the last 12months prior to the study inclusion date

• A recent change in analgesic medication (i.e., new agent or change in agent doseless than 1 week prior to the first stimulation session) or a planned change inanalgesic medication during the course of the study (change in agent, change indose), Note: modification of analgesic medication during the study is possible butmust be recorded

• Ongoing acute infection, surgery or trauma during the study

• Concurrent subject participation in another clinical study

• Subject is unable to sign informed consent